Last reviewed · How we verify
3 ampoules of Hylan GF-20
3 ampoules of Hylan GF-20 is a Small molecule drug developed by University of Sao Paulo General Hospital. It is currently FDA-approved. Also known as: 3 ampoules of Synvisc Classic.
At a glance
| Generic name | 3 ampoules of Hylan GF-20 |
|---|---|
| Also known as | 3 ampoules of Synvisc Classic |
| Sponsor | University of Sao Paulo General Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- 3 ampoules of Hylan GF-20 CI brief — competitive landscape report
- 3 ampoules of Hylan GF-20 updates RSS · CI watch RSS
- University of Sao Paulo General Hospital portfolio CI
Frequently asked questions about 3 ampoules of Hylan GF-20
What is 3 ampoules of Hylan GF-20?
3 ampoules of Hylan GF-20 is a Small molecule drug developed by University of Sao Paulo General Hospital.
Who makes 3 ampoules of Hylan GF-20?
3 ampoules of Hylan GF-20 is developed and marketed by University of Sao Paulo General Hospital (see full University of Sao Paulo General Hospital pipeline at /company/university-of-sao-paulo-general-hospital).
Is 3 ampoules of Hylan GF-20 also known as anything else?
3 ampoules of Hylan GF-20 is also known as 3 ampoules of Synvisc Classic.
What development phase is 3 ampoules of Hylan GF-20 in?
3 ampoules of Hylan GF-20 is FDA-approved (marketed).
Related
- Manufacturer: University of Sao Paulo General Hospital — full pipeline
- Also known as: 3 ampoules of Synvisc Classic
- Compare: 3 ampoules of Hylan GF-20 vs similar drugs
- Pricing: 3 ampoules of Hylan GF-20 cost, discount & access